TTR mouse Monoclonal Antibody(5D2)

This gene encodes transthyretin, one of the three prealbumins including alpha-1-antitrypsin, transthyretin and orosomucoid. Transthyretin is a carrier protein; it transports thyroid hormones in the plasma and cerebrospinal fluid, and also transports retinol (vitamin A) in the plasma. The protein consists of a tetramer of identical subunits. More than 80 different mutations in this gene have been reported; most mutations are related to amyloid deposition, affecting predominantly peripheral nerve and/or the heart, and a small portion of the gene mutations is non-amyloidogenic. The diseases caused by mutations include amyloidotic polyneuropathy, euthyroid hyperthyroxinaemia, amyloidotic vitreous opacities, cardiomyopathy, oculoleptomeningeal amyloidosis, meningocerebrovascular amyloidosis, carpal tunnel syndrome, etc.

Introducing the TTR Mouse Monoclonal Antibody (5D2), a cutting-edge product designed to revolutionize the field of biomedical research. This highly specific antibody is meticulously engineered to target Transthyretin (TTR), a protein associated with various pathological conditions.

The TTR Mouse Monoclonal Antibody (5D2) boasts exceptional affinity and selectivity, enabling precise detection and quantification of TTR in biological samples. Its superior performance is attributed to the advanced hybridoma technology employed during its development, ensuring consistent and reliable results.

This antibody exhibits remarkable stability and robustness, making it an ideal tool for a wide range of applications, including immunohistochemistry, western blotting, and enzyme-linked immunosorbent assays (ELISA). Its versatility allows for seamless integration into diverse experimental setups, facilitating comprehensive investigations into TTR-related diseases.

Furthermore, the TTR Mouse Monoclonal Antibody (5D2) is manufactured under stringent quality control measures, guaranteeing batch-to-batch consistency and reproducibility. Its formulation adheres to the highest industry standards, ensuring optimal performance and reliability in every experiment.

In summary, the TTR Mouse Monoclonal Antibody (5D2) represents a breakthrough in antibody technology, offering researchers an invaluable tool to unravel the complexities of TTR-associated pathologies. With its exceptional specificity, stability, and versatility, this antibody is poised to drive advancements in biomedical research and pave the way for novel therapeutic interventions.